Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A(TW:1762)
NT$31.05+-0.35 (+0.32%)
TW:1762
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A financials statements
NT$31.05
At close:+-0.35 (+0.32%)
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A (1762) Ratios
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A Ratios
TW:1762's free cash flow for Q2 2026 was NT$92.98M. For the 2026 fiscal year, TW:1762's free cash flow was decreased by NT$-15.44M and operating cash flow was NT$108.43M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.97 | 3.39 | 2.15 | 2.36 | 2.14 |
| Quick Ratio | 0.96 | 1.11 | 0.69 | 1.02 | 0.95 |
| Cash Ratio | 0.61 | 0.52 | 0.32 | 0.49 | 0.31 |
| Solvency Ratio | -0.04 | 0.18 | 0.25 | 0.46 | 0.36 |
| Operating Cash Flow Ratio | 0.40 | 1.10 | -0.08 | 1.19 | 0.35 |
| Short-Term Operating Cash Flow Coverage | 0.71 | 3.09 | -0.13 | 7.34 | 1.46 |
| Net Current Asset Value | NT$ -171.13M | NT$ 35.43M | NT$ -33.63M | NT$ 77.87M | NT$ -129.41M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.19 | 0.18 | 0.23 | 0.13 | 0.17 |
| Debt-to-Equity Ratio | 0.26 | 0.26 | 0.36 | 0.19 | 0.26 |
| Debt-to-Capital Ratio | 0.21 | 0.20 | 0.27 | 0.16 | 0.21 |
| Long-Term Debt-to-Capital Ratio | 0.16 | 0.17 | 0.17 | 0.14 | 0.17 |
| Financial Leverage Ratio | 1.40 | 1.42 | 1.54 | 1.43 | 1.51 |
| Debt Service Coverage Ratio | -0.16 | 1.58 | 0.92 | 5.71 | 3.62 |
| Interest Coverage Ratio | -19.10 | 0.30 | 14.45 | 59.17 | 156.36 |
| Debt to Market Cap | 0.59 | 0.33 | 0.27 | 0.12 | 0.15 |
| Interest Debt Per Share | 14.81 | 11.54 | 15.86 | 7.92 | 9.76 |
| Net Debt to EBITDA | -12.38 | 2.29 | 1.72 | 0.41 | 0.86 |
| Profitability Margins | |||||
| Gross Profit Margin | -1.10% | 29.27% | 36.30% | 45.43% | 49.07% |
| EBIT Margin | -29.69% | 5.83% | 16.92% | 28.01% | 25.89% |
| EBITDA Margin | -5.91% | 20.61% | 26.17% | 35.13% | 33.66% |
| Operating Profit Margin | -39.70% | 0.47% | 13.46% | 27.14% | 26.84% |
| Pretax Profit Margin | -31.77% | 4.25% | 15.98% | 27.55% | 25.72% |
| Net Profit Margin | -30.30% | 3.94% | 12.70% | 22.00% | 20.72% |
| Continuous Operations Profit Margin | -30.30% | 3.94% | 12.70% | 22.02% | 18.14% |
| Net Income Per EBT | 95.37% | 92.68% | 79.44% | 79.87% | 80.54% |
| EBT Per EBIT | 80.01% | 902.27% | 118.76% | 101.50% | 95.83% |
| Return on Assets (ROA) | -5.65% | 1.11% | 5.12% | 10.21% | 9.15% |
| Return on Equity (ROE) | -7.90% | 1.58% | 7.91% | 14.59% | 13.85% |
| Return on Capital Employed (ROCE) | -8.07% | 0.15% | 6.47% | 14.55% | 13.86% |
| Return on Invested Capital (ROIC) | -7.32% | 0.13% | 4.60% | 11.33% | 10.74% |
| Return on Tangible Assets | -5.65% | 1.11% | 5.13% | 10.22% | 9.15% |
| Earnings Yield | -17.92% | 2.05% | 5.96% | 9.16% | 7.96% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.33 | 6.76 | 8.40 | 6.78 | 5.09 |
| Payables Turnover | 28.10 | 23.73 | 12.89 | 8.08 | 12.71 |
| Inventory Turnover | 1.13 | 0.98 | 1.10 | 1.41 | 1.31 |
| Fixed Asset Turnover | 0.39 | 0.61 | 0.91 | 1.08 | 1.04 |
| Asset Turnover | 0.19 | 0.28 | 0.40 | 0.46 | 0.44 |
| Working Capital Turnover Ratio | 0.94 | 1.37 | 2.33 | 2.72 | 2.92 |
| Cash Conversion Cycle | 352.85 | 409.71 | 347.71 | 267.69 | 322.20 |
| Days of Sales Outstanding | 43.81 | 53.99 | 43.45 | 53.85 | 71.67 |
| Days of Inventory Outstanding | 322.03 | 371.11 | 332.57 | 259.03 | 279.26 |
| Days of Payables Outstanding | 12.99 | 15.38 | 28.31 | 45.19 | 28.73 |
| Operating Cycle | 365.84 | 425.10 | 376.02 | 312.88 | 350.92 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.57 | 6.13 | -0.86 | 9.46 | 2.83 |
| Free Cash Flow Per Share | 1.45 | 4.76 | -6.69 | 4.61 | -2.40 |
| Dividend Paid and CapEx Coverage Ratio | 1.85 | 2.80 | -0.12 | 1.54 | 0.42 |
| Capital Expenditure Coverage Ratio | 2.29 | 4.47 | -0.15 | 1.95 | 0.54 |
| Operating Cash Flow Coverage Ratio | 0.18 | 0.54 | -0.05 | 1.21 | 0.29 |
| Operating Cash Flow to Sales Ratio | 0.18 | 0.35 | -0.03 | 0.35 | 0.11 |
| Free Cash Flow Yield | 5.90% | 14.05% | -11.65% | 7.03% | -3.70% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -5.58 | 48.43 | 16.78 | 10.92 | 12.55 |
| Price-to-Sales (P/S) Ratio | 1.69 | 1.92 | 2.13 | 2.40 | 2.60 |
| Price-to-Book (P/B) Ratio | 0.44 | 0.77 | 1.33 | 1.59 | 1.74 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 16.95 | 7.12 | -8.59 | 14.23 | -27.02 |
| Price-to-Operating Cash Flow Ratio | 9.54 | 5.53 | -67.09 | 6.93 | 22.97 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | -0.61 | -0.39 | 0.67 | -0.51 |
| Enterprise Value Multiple | -40.97 | 11.60 | 9.87 | 7.25 | 8.59 |
| Enterprise Value | 1.95B | 3.22B | 5.39B | 5.39B | 5.59B |
| EV to EBITDA | -40.97 | 11.60 | 9.87 | 7.25 | 8.59 |
| EV to Sales | 2.42 | 2.39 | 2.58 | 2.55 | 2.89 |
| EV to Free Cash Flow | 24.29 | 8.87 | -10.40 | 15.08 | -30.02 |
| EV to Operating Cash Flow | 13.68 | 6.89 | -81.26 | 7.35 | 25.51 |
| Tangible Book Value Per Share | 55.55 | 43.99 | 43.18 | 41.07 | 37.29 |
| Shareholders’ Equity Per Share | 55.58 | 44.04 | 43.25 | 41.17 | 37.31 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.05 | 0.07 | 0.21 | 0.20 | 0.19 |
| Revenue Per Share | 14.49 | 17.68 | 26.94 | 27.30 | 24.94 |
| Net Income Per Share | -4.39 | 0.70 | 3.42 | 6.01 | 5.17 |
| Tax Burden | 0.95 | 0.93 | 0.79 | 0.80 | 0.81 |
| Interest Burden | 1.07 | 0.73 | 0.94 | 0.98 | 0.99 |
| Research & Development to Revenue | 0.21 | 0.15 | 0.12 | 0.12 | 0.13 |
| SG&A to Revenue | 0.18 | 0.14 | 0.11 | 0.13 | 0.12 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.56 | 8.17 | -0.25 | 1.26 | 0.44 |
Currency in TWD
